Aprea Therapeutics's total assets for Q3 2024 were $26.89M, a decrease of -10.25% from the previous quarter. APRE total liabilities were $4.95M for the fiscal quarter, a 12.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.